These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 15356827

  • 1. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis.
    Siwek GT, Dodgson KJ, de Magalhaes-Silverman M, Bartelt LA, Kilborn SB, Hoth PL, Diekema DJ, Pfaller MA.
    Clin Infect Dis; 2004 Aug 15; 39(4):584-7. PubMed ID: 15356827
    [Abstract] [Full Text] [Related]

  • 2. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.
    Trifilio S, Singhal S, Williams S, Frankfurt O, Gordon L, Evens A, Winter J, Tallman M, Pi J, Mehta J.
    Bone Marrow Transplant; 2007 Sep 15; 40(5):451-6. PubMed ID: 17589527
    [Abstract] [Full Text] [Related]

  • 3. Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis.
    Siwek GT, Pfaller MA, Polgreen PM, Cobb S, Hoth P, Magalheas-Silverman M, Diekema DJ.
    Diagn Microbiol Infect Dis; 2006 Jul 15; 55(3):209-12. PubMed ID: 16626917
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy.
    Trifilio SM, Bennett CL, Yarnold PR, McKoy JM, Parada J, Mehta J, Chamilos G, Palella F, Kennedy L, Mullane K, Tallman MS, Evens A, Scheetz MH, Blum W, Kontoyiannis DP.
    Bone Marrow Transplant; 2007 Apr 15; 39(7):425-9. PubMed ID: 17310132
    [Abstract] [Full Text] [Related]

  • 6. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.
    Marty FM, Cosimi LA, Baden LR.
    N Engl J Med; 2004 Feb 26; 350(9):950-2. PubMed ID: 14985500
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
    Marty FM, Lowry CM, Cutler CS, Campbell BJ, Fiumara K, Baden LR, Antin JH.
    Biol Blood Marrow Transplant; 2006 May 26; 12(5):552-9. PubMed ID: 16635790
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation.
    Leithauser M, Kahl C, Aepinus C, Prall F, Maruschke M, Riemer H, Wolff D, Jost K, Hilgendorf I, Freund M, Junghanss C.
    Transpl Infect Dis; 2010 Jun 26; 12(3):251-7. PubMed ID: 20002357
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient.
    Tong SY, Peleg AY, Yoong J, Handke R, Szer J, Slavin M.
    Transpl Infect Dis; 2007 Sep 26; 9(3):241-3. PubMed ID: 17605752
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.